全文获取类型
收费全文 | 99387篇 |
免费 | 6586篇 |
国内免费 | 3801篇 |
专业分类
耳鼻咽喉 | 584篇 |
儿科学 | 2670篇 |
妇产科学 | 1713篇 |
基础医学 | 24292篇 |
口腔科学 | 1322篇 |
临床医学 | 7635篇 |
内科学 | 20003篇 |
皮肤病学 | 1514篇 |
神经病学 | 3970篇 |
特种医学 | 1650篇 |
外国民族医学 | 10篇 |
外科学 | 4986篇 |
综合类 | 12457篇 |
现状与发展 | 24篇 |
预防医学 | 12298篇 |
眼科学 | 874篇 |
药学 | 7228篇 |
24篇 | |
中国医学 | 1394篇 |
肿瘤学 | 5126篇 |
出版年
2024年 | 101篇 |
2023年 | 1097篇 |
2022年 | 2944篇 |
2021年 | 3532篇 |
2020年 | 2973篇 |
2019年 | 2722篇 |
2018年 | 2677篇 |
2017年 | 2786篇 |
2016年 | 3046篇 |
2015年 | 3452篇 |
2014年 | 5348篇 |
2013年 | 6036篇 |
2012年 | 5207篇 |
2011年 | 6144篇 |
2010年 | 4944篇 |
2009年 | 4774篇 |
2008年 | 4742篇 |
2007年 | 4895篇 |
2006年 | 4388篇 |
2005年 | 3880篇 |
2004年 | 3445篇 |
2003年 | 3101篇 |
2002年 | 2478篇 |
2001年 | 2369篇 |
2000年 | 2110篇 |
1999年 | 1842篇 |
1998年 | 1737篇 |
1997年 | 1747篇 |
1996年 | 1578篇 |
1995年 | 1655篇 |
1994年 | 1553篇 |
1993年 | 1313篇 |
1992年 | 1153篇 |
1991年 | 1041篇 |
1990年 | 913篇 |
1989年 | 746篇 |
1988年 | 726篇 |
1987年 | 572篇 |
1986年 | 469篇 |
1985年 | 835篇 |
1984年 | 619篇 |
1983年 | 413篇 |
1982年 | 350篇 |
1981年 | 293篇 |
1980年 | 222篇 |
1979年 | 193篇 |
1978年 | 164篇 |
1977年 | 115篇 |
1976年 | 97篇 |
1974年 | 49篇 |
排序方式: 共有10000条查询结果,搜索用时 23 毫秒
71.
72.
D Gröne† R Treudler† EM de Villiers‡ R Husak† CE Orfanos† ChC Zouboulis†§ 《Journal of the European Academy of Dermatology and Venereology》2006,20(2):202-205
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment. 相似文献
73.
Hepatitis C virus (HCV) infection is a major health care issue in liver and kidney transplantation. Besides negatively affecting both patient and graft survival, HCV is associated with a heightened risk for new onset diabetes mellitus (NODM). The mechanisms underlying the diabetogenicity of HCV are complex but are likely to involve insulin resistance caused by inhibitory actions of the virus on insulin regulatory pathways in the liver. The resultant glucose dysregulation is an important determinant of increased morbidity and mortality in liver and kidney recipients. This review highlights the concerns for outcomes in HCV-positive liver and kidney transplant patients with particular focus on the interrelationship between hepatitis C and diabetes. Data about the potential role of calcineurin inhibitors, corticosteroids and mycophenolate mofetil in HCV infection and HCV-associated NODM will also be discussed. 相似文献
74.
MASAFUMI IKEDA SHIGETOSHI FUJIYAMA MOTOHIKO TANAKA MICHIO SATA TATSUYA IDE HIROSHI YATSUHASHI HIROSHI WATANABE 《Journal of gastroenterology and hepatology》2006,21(1):122-128
Background and Aim: This study investigated the clinical features of hepatocellular carcinoma in patients with sustained virological response to interferon for hepatitis C viral (HCV) infection. Methods: A total of 7715 patients with HCV infection were treated with interferon and followed up for more than 1 year after withdrawal of interferon in 64 Japanese hospitals and clinics between July 1988 and August 2001. Sustained virological response was obtained in 2515 (32.6%) patients. Of these 2515 patients, clinical data were collected for 38 patients in whom hepatocellular carcinoma developed. Sustained virological response was defined as HCV RNA negativity more than 6 months after the termination of interferon. Results: All patients were HCV RNA negative at the time of diagnosis of hepatocellular carcinoma. The median period until the detection of hepatocellular carcinoma was 4.7 years (range 1.4–9.0 years). There were significant improvements in hepatic function including serum albumin, aspartate aminotransferase, alanine aminotransferase, indocyanine green test, platelet count and histological activity grade in comparison with those before interferon therapy and at the onset of hepatocellular carcinoma. The maximum tumor size in patients without medical follow‐up for 1 year or more (median: 60 mm) was significantly larger than in patients who were periodically followed up for 6 months or less (median: 25 mm) (P = 0.002). Conclusions: The present findings emphasize the importance of regular medical follow up of patients with HCV infection, as even patients showing a sustained virological response to interferon and in whom hepatic function has improved have the potential to develop hepatocellular carcinoma. 相似文献
75.
Traditional Chinese Medicine Compound Mianbu Mixfang Is Effective in Treating Immunological Infertility: a Female Mice 总被引:1,自引:0,他引:1
《生殖与避孕(英文版)》2002,(1)
Key words:anTraditional Chinese Medicine has been used to treat various diseases in Chinathousands of years before the introduction of Western Medicine and practices.Inrecent years it has also been used to treat the immunological infertility caused byAs A… 相似文献
76.
采用免疫组织化学S-P法检测52例手术切除乳腺癌组织c-erbB-2蛋白和HSV-1、HSV-2表达情况。结果发现癌组织中c-erbB-2阳性34例(65.4%);HSV-1阳性38例(73.1%);HSV-2阳性15例(28.8%)。癌旁组织32例,阳性分别为3例(9.4%);12例(37.5%);2例(6.3%)。乳腺癌中c-erbB-2阳性率明显高于癌旁组织。乳腺癌及癌旁的HSV-1阳性率明 相似文献
77.
静脉毒瘾者84例HGV感染状况 总被引:8,自引:0,他引:8
目的调查庚型肝炎病毒(HGV)在静脉毒瘾者中的感染状况。方法采用逆转录聚合酶链反应(RT-PCR)检测84例静脉毒瘾者血浆标本。HGVRNA经热变性法提取后逆转录为cDNA,在HGV5′非编码区(5′NCR)设计两对引物进行巢式扩增,产物为238bp,并经限制性内切酶HpaⅡ鉴定扩增产物来自HGV。结果84例中有15例为HGVRNA阳性,阳性率为17.9%。HGVRNA阳性病例中11例合并丙型肝炎病毒感染(11/15)。结论静脉毒瘾者是HGV感染的高危人群;不洁注射是获得HGV感染的重要途径。 相似文献
78.
Cytologic evaluation of the CSF is often difficult when trying to distinguish between truly neoplastic and reactive cells. Several non-neoplastic conditions may be associated with atypical cells in the CSF, a fact the clinician has to consider to avoid inadequate aggressive theraphies. We report here three patients with infectious meningitis (due to Herpes zoster virus in two, and neuroborreliosis in one) and cytologically atypical cerebrospinal fluid lymphocytes. Further characterization showed that the pleocyrosis in these patients was of reactive origin. Cytomorphology is frequently insufficient and histochemical, immuncytochemical and cellular genome analysis techniques may help differentiate atypical reactive cells from neoplastic cells. 相似文献
79.
马尔尼菲青霉病不同类型病变中免疫反应观察 总被引:2,自引:0,他引:2
选用2组病变类型不同的6例马尔尼菲青霉病人病变组织,采用免疫组化PAP法,观察病变组织中l8淋巴细胞、巨噬细胞、IgG、IgM、乙等免疫指标。结果发现马尔尼菲青霉病的病变类型取决于机体的免疫功能状态,人体抗马尔尼菲青霉免疫以细胞免疫为主,组织中T细胞的存在对于杀灭真菌、局限病变具有积极意义;体液免疫特别是特异性抗体的出现除具有促进细胞免疫功能外,可能也是脓肿成因之一。 相似文献
80.
Hitoshi Tajiri M.D Kosuke Kozaiwa M.D Tokuzo Harada M.D Yoshikazu Ozaki M.D Kazunori Miki M.D Kazuo Shimizu M.D Shintaro Okada M.D. 《Pediatrics international》1991,33(3):323-326
We assessed the efficacy of a government-sponsored mass protection program in Osaka, Japan, for perinatal HBV infection in infants born to HBeAg positive HBV carrier mothers. We also evaluated the impact of optional follow-up procedures in such infants, including an evaluation of anti-HBs response and a booster dose of HBV vaccine for poor responders. The results demonstrated that this mass protection program protected 94.4% of the infants from perinatal HBV infection in the Osaka area. However, the proportion of infants with an unprotective level of anti-HBs was higher in the standard group than in the follow-up group both at 1.0 and 1.5 years of age, which was also the case for HBV events. Furthermore, the present study showed that a booster dose of vaccine in poor responders was very effective in promoting an anti-HBs response. In conclusion, we recommend that a follow-up blood test to confirm a response of anti-HBs to HBV vaccine should be performed at 4–8 weeks after the third injection of HBV vaccine in infants born to HBeAg positive HBV carrier mothers. We also recommend that a booster injection of HBV vaccine should be immediately given to poor responding infants who otherwise are at a considerable risk of developing HBV infection in late infancy. 相似文献